{
    "2021-04-30": [
        [
            {
                "time": "2023-10-05",
                "original_text": "The Eaton Vance Fund sells Novartis, Pfizer",
                "features": {
                    "keywords": [
                        "Eaton Vance Fund",
                        "sells",
                        "Novartis",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Pharma Stock Roundup: Big Drugmakers Q1 Earnings, Resumption of JNJ US COVID-19 Jabs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "Big Drugmakers",
                        "Q1 Earnings",
                        "Resumption",
                        "JNJ",
                        "US",
                        "COVID-19 Jabs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Alnylam's (ALNY) Q1 Loss Narrower Than Expected, Revenues Beat",
                "features": {
                    "keywords": [
                        "Alnylam",
                        "Q1 Loss",
                        "Narrower",
                        "Expected",
                        "Revenues Beat"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}